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Abstract Three novel peptides were isolated from the venomous
saliva of predatory reduviids. They were identified by mass
spectrometry and HPLC analysis and consist of 34^36 amino
acid residues. They are relatively homologous to the calcium
channel blockers g-conotoxins from marine cone snails and
belong to the four-loop Cys scaffold structural class. Ptu1, the
shortest peptide, was chemically synthesized (sPtu1) and co-
eluted with its native form. Circular dichroism spectra of the
sPtu1 showed a high content of L-turns similar to that of g-
conotoxins GVIA and MVIIA. Electrophysiological experiments
demonstrated that sPtu1 reversibly blocks the N-type calcium
channels expressed in BHK cells. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The venom of poisonous predators has been a great source
of novel peptides with a notable potential for use in agricul-
ture and in medicine. Such peptides have also been invaluable
biochemical tools for the study of ion channels in animal cells.
Toxic peptides targeting ion channels have been frequently
isolated from snakes, scorpions, marine cone snails, spiders,
and other animals [1,2]. Assassin bugs (Arthropoda: Insecta:
Hemiptera: Reduviidae) are one of the largest and morpho-
logically diverse families of true bugs feeding on crickets, cat-
erpillars and other insects [3]. Some assassin bug species are
bloodsucking parasites of mammals, even of humans [4]. The
toxic saliva of the predatory assassin bugs contains a complex
mixture of small and large peptides for diverse uses such as
immobilizing and pre-digesting their prey, and defense against
competitors and predators [5]. Reduviid venomous saliva as
well as the venomous material of other insects is a new po-
tential source of peptic material for the study and character-
ization of cell receptors and receptor subtypes that could lead
to the development of novel agrochemicals and pharmaceut-
icals.
In this work, we describe for the ¢rst time the isolation,
chemical characterization and biological activities of three
novel peptides originating from the venomous saliva of assas-
sin bugs. Because of the low quantities of material obtained
from these insects, the peptides were identi¢ed by a non-con-
ventional method based on mass spectrometry analysis of the
crude material following liquid chromatography separation
and chemical characterization of the most abundant low mo-
lecular weight components.
2. Materials and methods
2.1. Venom preparation
Crude assassin bug venomous saliva was obtained by electrical
stimulation of ¢eld-collected Peirates turpis, Agriosphodrus dohrni,
and Isyndus obscurus assassin bugs from Mt. Nijosan, Mt. Takaya-
suyama, and Mt. Sigisan respectively. The crude venomous saliva of
each species was ¢rst diluted with 0.1% aqueous tri£uoroacetic acid
(TFA) and centrifuged at 14 000 rpm for 30 min at 4‡C. The super-
natant was stored at 320‡C until further use.
2.2. Puri¢cation of assassin bug peptides
The extracted material from the saliva was fractionated by reversed-
phase HPLC on a semi-preparative C8 column (5C8MS, 10U250 mm,
Nacalai Tesque, Japan). The column was equilibrated in 0.1% TFA,
and eluted with a 60 min linear gradient of 0^60% acetonitrile con-
taining 0.1% TFA (2 ml/min). Fractions were collected manually by
monitoring the absorbance at 215 nm. The reversed-phase fractions
were further puri¢ed by cation exchange chromatography on a TSK
gel sulfopropyl column (SP-5PW, 4.6U75 mm, Tosoh, Japan). The
reversed-phase fractions were separated using a linear gradient of 1 M
acetic acid pH 2.9 to 2 M ammonium acetate in 1 M acetic acid pH
5.9, in 120 min (1 ml/min). Absorbance was monitored at 280 nm and
the components were collected manually and dried under vacuum.
2.3. Mass spectrometry
Matrix-assisted laser desorption/ionization (MALDI) mass spectra
were obtained on a Voyager Elite time-of-£ight (TOF) spectrometer
(PerSeptive Biosystems Inc., Framingham, MA, USA) equipped with
a model VSL-337ND nitrogen laser (Laser Science, Newton, MA,
USA). The experiments were performed as reported previously [6].
2.4. Biological activity
Invertebrate toxicity of assassin bug peptides was tested using crick-
ets and cutworms. Lepidopteran larvae (Spodoptera litura, 2^3 mg)
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were injected into the pronotum with glass capillary pipettes contain-
ing up to 300 nl of diluted venom or fractions resuspended in water,
and placed in 55 mm diameter plastic petri dishes for observation.
Paralytic and lethal e¡ects were observed at di¡erent time intervals up
to 48 h. Crickets (Grillus bimaculus, 50^70 mg) were injected intra-
thoracically between the second and third pair of legs with 2 Wl of
peptide using a 10 Wl microsyringe. Animal toxicity was also evaluated
on gold¢sh and mice. Gold¢sh (2^3 g) were injected i.p. with 7 Wg of
assassin bug peptide previously diluted in deionized water. Male mice
(C57BL/6, 20 g) were tested by i.c.v. and i.v. injection. Up to 7 Wg of
assassin bug peptide was diluted up to 5 Wl with bovine serum albu-
min (BSA) solution (20 mg/ml in 0.9% NaCl) and injected with a 10 Wl
microsyringe ¢tted with a glass capillary mid-way between the left eye
and the left ear. Negative controls were done with saline solution only
and positive controls with g-conotoxins GVIA or MVIIA (Peptide
Institute, Osaka, Japan). Mice were placed in glass jars for observa-
tion of toxicity symptoms up to 48 h.
2.5. Sequence determination and enzymatic digestion
Assassin bug peptides were reduced with tributylphosphine (Nacalai
Tesque, Japan) and were simultaneously alkylated with 4-vinyl-pyri-
dine (Wako, Japan), in 0.5 M NaHCO3 bu¡er (pH 8.3) for 2 h at
37‡C in the dark. Hydrolysis of Ado1 and lob1 RA peptides with
endoproteinase type XVII-B (Glu-C) from Staphylococcus aureus
strain V8 was carried out as previously reported [7]. RA peptides
and endoproteinase-digested fractions were analyzed by MALDI-
TOF MS and sequenced by Edman degradation on a Shimadzu
PPSQ-10 automated gas phase sequencer.
2.6. Peptide synthesis
Ptu1 was chemically synthesized by a solid phase method using
Fmoc methodology on an Applied Biosystems 433 A peptide synthe-
sizer. Fmoc-Leu-Wang resin (Watanabe Chemical Industries, Ltd.,
Japan) was used to provide a free carboxyl at the C-terminal of
synthetic Ptu1-OH (sPtu1). Chemical synthesis, cleavage and depro-
tection of peptide resins were performed as previously described [8].
The crude synthetic peptide was dissolved in 20% aqueous acetoni-
trile, and the reduced peptide separated by RP-HPLC on a semipre-
parative C8 column (5C8MS, 10U250 mm, Nacalai Tesque, Japan).
The six free cysteine residues were allowed to oxidize by air exposure
for 48 h at room temperature in 1 M aqueous guanidine hydrochlor-
ide containing 0.1 M ammonium acetate solution containing 1 mM
reduced glutathione/0.1 mM oxidized glutathione.
2.7. Capillary electrophoresis
Capillary zone electrophoresis (CZE) analyses were performed on a
Jasco system equipped with a UV detector and a 70 cm 20 mM
sodium citrate bu¡er (pH 2.5) (Applied Biosystems, USA) was used
for the analysis. Samples dissolved in migration bu¡er were applied
hydrodynamically to the capillary and analyses were performed with a
20 kV constant voltage drop. E¥uent was monitored at 210 nm.
2.8. Disul¢de bridge determination
Partial reduction of Ptu1 with Tris-(2-carboxy-ethyl)phosphine
(TCEP, Tokyo Kasei Kogyo Co., Japan) and cyanylation by 1-cya-
no-4-dimethylamino-pyridinium tetra£uoroborate (CDAP, Sigma
Co., USA) followed by chemical cleavage of partially reduced pep-
tides was performed as reported previously [9].
2.9. Circular dichroism (CD) measurements
CD spectra were obtained on a Jasco J-725 spectropolarimeter
(Jasco, Japan). The spectra were measured from 260 to 190 nm in
60% tri£uoroethanol, pH 7.1, at room temperature, with a 1 mm path
length cell. The concentration of the peptides was 30 WM. Data from
10 separate recordings were averaged and analyzed by the method of
Bohm et al. [10].
2.10. Whole cell patch clamp recordings
The whole cell Ca2 channel currents were recorded from BHK-
N101 cells (baby hamster kidney cell line, generously supplied by Dr.
Y. Mori [11]) that stably express rabbit voltage-dependent N-type
Ca2 channel K1B subunit, L1A subunit, and K2/N subunit. Ba2 (2
mM) was used as a charge carrier in the bath solution (137 mM
NaCl, 5.4 mM KCl, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES,
2 mM BaCl2, pH 7.4, adjusted with NaOH) at room temperature.
Ba2 channel currents through P/Q-type Ca2 channels were recorded
from BHK-BI cells [12], and so were L-type Ca2 channel currents
from BHK6 cells, kindly supplied by Dr. Y. Mori. BHK6 cells were
transiently expressed with rat brain K1C subunit (rbCII) that was
generously supplied by Dr. T.P. Snutch [13]. The resistance of the
heat-polished microelectrodes was kept between 2 and 4 M6 when
¢lled with the internal solution (120 mM CsCl, 20 mM TEACl, 14
mM EGTA, 5 mM MgATP, 5 mM Na2 creatine phosphate, 0.2 mM
GTP, 10 mM HEPES, 0.2 mM cAMP; pH 7.3 adjusted with CsOH).
Currents were measured using Patch/Whole Cell Clamp Ampli¢er
(Nihon Kohden, Tokyo, Japan) or Axopatch 1D (Axon Instruments,
Inc., Foster City, CA, USA), and A/D converter (Digidata 1200,
Axon Instruments, Inc., Foster City, CA, USA). Voltage clamp pro-
tocols and data acquisitions were performed using pCLAMP6 soft-
ware (Axon Instruments, Inc., Foster City, CA, USA). Ba2 currents
through Ca2 channels were elicited by giving test pulses from a
holding potential at 3100 mV to 0 mV for 100 ms at 0.1 Hz. Ptu1
was diluted in the bath solution containing 0.1% BSA and applied to
cells via a concentration clamp apparatus (Vibraspec, Inc., Philadel-
phia, PA, USA).
3. Results and discussion
3.1. Peptide characterization and structure
A preliminary MALDI-TOF MS screening of the assassin
bug venomous saliva permitted us to detect molecular weight
components from 1 to 30 kDa (data not shown). The venom-
ous saliva was fractionated by reversed-phase HPLC and all
the fractions were analyzed by MALDI-TOF MS (Fig. 1).
The most abundant HPLC fractions from each assassin bug
species contained components having molecular masses from
2 to 5 kDa and higher than 10 kDa. The HPLC fractions
containing larger amounts of material with low molecular
masses and a relatively high purity of components were se-
lected for further puri¢cation and chemical characterization.
HPLC fractions with molecular masses of 3615.3, 3781.2 and
3938.6 Da from the species P. turpis, A. dohrni, and I. obscu-
rus respectively were chosen and subsequently puri¢ed by cat-
ion exchange chromatography. After cation exchange puri¢-
cation, each peptide was obtained with a purity higher than
98% as con¢rmed by MALDI-TOF MS and CZE (data not
shown). The three peptides were designated Ptu1, Ado1, and
lob1 according to the name of the genus and species of each
reduviid. They were reduced and alkylated by TCEP and 4-
vinyl-pyridine showing a 630 Da increase in their molecular
weights indicating the presence of three disul¢de bonds (data
not shown). The data obtained from automated Edman se-
quencing of the reduced-alkylated peptides allowed the com-
plete determination of all three sequences (Table 1). The re-
duced-alkylated peptides Ado1 and lob1 were also digested
with Glu-C and their digested fragments analyzed by MAL-
DI-TOF MS and Edman degradation to con¢rm their amino
acid sequences. The calculated molecular masses of the pep-
tides were compared to the molecular masses obtained from
MALDI-TOF MS. Ptu1, Ado1 and lob1 have measured mo-
lecular weights of 3615.1, 3781.3 and 3938.5 Da respectively.
Theoretical molecular weights calculated from sequence data
and assuming a free C-terminal carboxylic acid and the pair-
ing of the six cysteine residues into three disul¢de bridges were
respectively 3615.2, 3781.7 and 3938.4 (Table 1). Although the
peptides Ptu1, Ado1, and lob1 belong to di¡erent Reduviidae
genera, their amino acid sequence motif was well conserved
with some point mutations (Table 1). The assassin bug pep-
tides are basic (Ptu1, Ado1) and neutral (lob1) and are rela-
tively homologous to the g-conotoxins. Among other amino
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acid residues, g-conotoxins and assassin bug peptides have
well conserved the neutral residue Gly11 and the basic resi-
dues R43 or K43 (Table 1). The presence of aspartic and
glutamic residues at the very end of the N-terminal tail of
the assassin bug peptides is also noteworthy. Such a charac-
teristic negatively charged N-terminal region has also been
observed at the N-terminal tail of the calcium channel blocker
g-conotoxin PnVIB from Conus pennaceus [14] (Table 1).
Such a negatively charged region does not seem to a¡ect bio-
logical activity in molluscan neurons [14], but perhaps it is
important for recognition of di¡erent known receptors on
calcium channels. Although the homology of assassin bug
peptides and conotoxins is low (6 44%), it is well known
that g-conotoxins with marked primary structure di¡erences
are usually very speci¢c for the same type of calcium ion
channel [15]. As an example, the homology between the N-
type calcium channel toxins GVIA and MVIIA is 32%. The
homology of GVIA and Ptu1 is 37%, and that of GVIIA and
Ptu1 is 41%. Therefore, the primary structure homology of
assassin bug to the g-conotoxins is a substantial clue for in-
vestigating their biological activity in di¡erent types of calci-
um channels.
In order to carry out chemical and biological characteriza-
tion, Ptu1, the shorter peptide, was synthesized in its free
carboxylated form (sPtu1). The identity between the synthetic
peptide and the native one was veri¢ed by MALDI-TOF MS
and Edman degradation. In a co-injection experiment using
capillary electrophoresis, pure native Ptu1 and pure sPtu1 co-
eluted in a single peak indicating most likely their identical
structural conformation. The sPtu1 peptide was subsequently
used to determine the disul¢de bridge pairing. sPtu1 was re-
acted in the presence of TCEP and CDAP and two partially
reduced cyanylated protein isomers were obtained with mo-
lecular masses of 3667.1 Da each. After cleavage with 1 N
NH4OH followed by TCEP reduction and MALDI-TOF
analysis, the identity of the cyanylated isomers was achieved
demonstrating the links between Cys5-Cys20 and Cys19-Cys33.
The disul¢de bond between C12-C26 was inferred since all
other cystine residues were accounted for. According to these
results, the disul¢de bonding pattern found for Ptu1 was sim-
ilar to that described for g-conotoxins and all other four-loop
peptides.
Since the assassin bug peptides were homologous in their
primary sequence and possessed a similar disul¢de bridge pat-
Fig. 1. MALDI-TOF spectra and HPLC chromatograms of the venomous saliva of P. turpis, A. dohrni and I. obscurus.
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tern to the g-conotoxins, the secondary structures of the syn-
thetic peptides Ptu1, GVIA and MVIIA were analyzed by CD
and compared (Fig. 2). Their secondary structure component
values were K-helical 10.5%, 17.9%, 16.9%; antiparallel L-
sheet 4.2%, 29.1%, 30.0%; parallel L-sheet 2.9%, 3.3%,
2.6%; L-turns 34.6%, 18.8%, 43.1%; and random coil 58.0%,
24.6%, 20.6% for Ptu1, GVIA and MVIIA respectively. The
CD spectra of Ptu1 and MVIIA were quite similar from 200
to 260 nm with minima at around 205 nm typical of an un-
ordered or random coil structure [16]. However, GVIA
showed a di¡erent spectrum in the 200^260 nm range, a
GVIA analog where Tyr27 was replaced by Ala27, Y27A-
GVIA, showed that the phenolic ring of Tyr27 of GVIA
has a dominant contribution to its CD spectrum and it was
responsible for the positive band observed in the range from
195 to 205 nm [17]. Y27A-GVIA and MVIIA showed similar
CD spectra in aqueous solution [17]. Both MVIIA and Ptu1
lack this aromatic chromophore at their C-terminus. More-
over, all three peptides seem to be full of L-turns, which is a
common characteristic of the four-loop sca¡old conotoxins.
The most important CD spectral data seem to come from the
antiparallel L-sheet analysis of Ptu1 and g-conotoxins. That
is, the antiparallel L-sheet fractions in GVIA and MVIIA
scored 29.1% and 30.0%, respectively, while that in Ptu1
was only 4.2%. The antiparallel L-sheet fraction in Ptu1 seems
to be replaced by a high content of unordered structure. The
triple-stranded antiparallel L-sheets in the g-conotoxin family
and the low content of antiparallel L-sheet in Ptu1 may be an
important factor for biological activity. However, a 3D struc-
ture determination of Ptu1 is required to con¢rm this sugges-
tion.
3.2. Biological activity
The structural similarity between assassin bug peptides and
Fig. 2. CD spectra of Ptu1, GVIA, and MVIIA.
Table 1
Alignment of the assassin bug peptides with the sequences of cone snail toxins [14,18^23]
The multiple sequence alignment was done with ClustalX (http://www-igbmc.u-strasbg.fr/BioInfo/ClustalX/Top.html) using a BLOSUM amino
acid substitution. Theoretical pI values for oxidized cysteine were calculated by the GPMAW software (ChemSW, California, USA). Homology
values are relative to Ptu1 and were calculated by ClustalW at http://www2.ebi.ac.uk/clustalW/ using a BLOSUM matrix.
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g-conotoxins led us to test Ptu1 for toxicity towards di¡erent
animals. The assassin bug peptides were assayed in vivo by
direct injection into the body of gold¢sh (i.p.), mice (i.c.v.),
cutworm larvae and crickets. However, Ptu1 showed no toxic
symptoms in either vertebrates or invertebrates during a peri-
od of 48 h post-injection. Nevertheless, because of the relative
identity of the assassin bug peptides with g-conotoxins, elec-
trophysiological experiments were carried out using di¡erent
BHK cell lines expressing the N-, L-, or P/Q-type calcium
channels in the presence and in the absence of Ptu1. Ptu1
produced a block of Ba2 currents (IC50W0.3 WM) through
the voltage-dependent N-type Ca2 channel (Fig. 3A). In con-
trast to g-conotoxin GVIA, which produces irreversible block
of N-type Ba2 channel currents (IC1006 0.1 WM) in BHK-
N101 cells [11], the block of Ba2 channel current produced
by Ptu1 was completely reversed on washout of the peptide
(Fig. 3A), which was in contrast to the irreversible block by
g-CgTx-GVIA (Fig. 3D). Ptu1 at 300 nM blocked Ba2 cur-
rents through the voltage-dependent N-type Ca2 channel to
52.9 þ 6.9% of control (100%) (mean þ S.E.M., n = 4, see Fig.
3B). However, Ptu1 produced a merely slight but reversible
block of Ba2 currents through other voltage-dependent Ca2
channels such as L-type Ca2 channel and P/Q-type Ca2
channel (76.4% and 76.3%, respectively, n = 2, Fig. 3C) from
BHK-BI cells and BHK6 cells expressing the K1A and K1C
subunits respectively. Thus Ptu1 blocked the N-type Ca2
channel most selectively among high voltage-activated Ca2
channels. Ado1 and lob1 were not tested for biological activ-
ity on calcium channels because of the small quantities of
material left after the in vivo assays.
Despite Ptu1’s low blocking capabilities in N-type calcium
channels, it should be noted that most N-type calcium channel
toxins isolated to date have IC50 values from picomolar to
micromolar depending mainly on the electrophysiology tech-
niques and the type of tissues or cells used [24,25]. Although
g-conotoxin GVIA is the most reliable parameter to compare
Fig. 3. E¡ect of Ptu1 on high voltage-activated Ca2 channels expressed in BHK cells. Ca2 channel currents were recorded with Ba2 (2 mM)
as a charge carrier. A: E¡ect of Ptu1 (300 nM) on Ba2 currents through the voltage-dependent N-type Ca2 channel K1B subunit expressed in
BHK-N101 cells together with L1A subunit and K2/N subunit. Ba2 currents were elicited by giving test pulses from a holding potential at 3100
mV to 0 mV for 100 ms as 0.1 Hz. Ptu1 was rapidly applied via a concentration clamp apparatus during the period indicated. Ba2 currents
recorded before and after (indicated as a and b, respectively) application of Ptu1 were superimposed in the inset. B: Summary of the block of
Ba2 currents through high voltage-activated Ca2 channels by Ptu1. C: E¡ects of Ptu1 on Ba2 currents through L-type Ca2 channel K1C
subunit expressed in BHK6 cells together with L1A subunit and K2/N subunit (left) and through P/Q-type Ca2 channel K1A subunit expressed
in BHK-B1 cells together with L1A subunit and K2/N subunit (right). D: Irreversible block of N-type Ca2 channel by g-CgTx-GVIA at
1037 M.
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and categorize the potency of N-type calcium channel block-
ers, we do not rule out that Ptu1 may act on other tissue cells
with similar or more potency than GVIA.
Ptu1 was not toxic to mice either when injected i.c.v. up to
7 Wg/mouse or when injected i.v. at the same concentration. In
addition, experiments using mast peritoneal cells from rats
have shown that Ptu1 does not release histamine at concen-
trations up to 10 Wg/ml (data not shown). In this respect, the
non-toxic e¡ects, the ion channel speci¢city and the fast re-
versible activity of Ptu1 could be an advantage over other
calcium channel peptides (i.e. g-conotoxins) for the design
of novel drugs for the treatment of N-type calcium channel-
related disorders. Further research should involve electrophy-
siological and binding experiments in vertebrate tissue cells
using sPtu1 and sAdo1 for determining more acutely their
biological targets as well as NMR studies for determining
their three-dimensional structures.
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